In general, these data suggest that AIMP2-DX2 is involved in NPC development, and genetic knockdown of AIMP2-DX2 suppresses tumor cell growth of NPC in vitro and in vivo. The gene discussed is AIMP2; the disease is nasopharyngeal carcinoma.